Post Marketing Information DHCPL 13/03/2018 Risk of serious neurologic adverse events, including encephalopathy, associated with cefepime particularly in patients with renal impairment who received doses that exceeded the recommendations
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Injection, Powder, For Solution 2,000 mg/vial Alexandra Hospital Changi General Hospital KK Women's and Children's Hospital Khoo Teck Puat Hospital National Cancer Centre Ng Teng Fong General Hospital National University Hospital Sengkang General Hospital Singapore General Hospital Tan Tock Seng Hospital Woodlands Health Campus
INTRAVENOUS Select a brand starting with the letter: C CEFEPIME KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1 G/VIAL [SIN14987P] CEFEPIME KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 G/VIAL [SIN14988P] CEFEVON POWDER FOR SOLUTION FOR INJECTION 2G/VIAL [SIN14156P]
INTRAVENOUS / INTRAMUSCULAR Select a brand starting with the letter: C CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL [SIN14658P]